BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Wu Q, Wang Y, Weng C, He Y, Gao M, Yang G, Li L, Chen F, Shi Y, Amiot BP, Nyberg SL, Bao J, Bu H. Novel spheroid reservoir bioartificial liver improves survival of nonhuman primates in a toxin-induced model of acute liver failure. Theranostics. 2018;8:5562-5574. [PMID: 30555564 DOI: 10.7150/thno.26540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Gong S, Wang T, Li L, Luo H, Wang J, Huang C, Zhou H, Chen G, Liu Z, Zhang Q, Jiang Y, Chen P. Soyasaponin II protects against acute liver failure through diminishing YB-1 phosphorylation and Nlrp3-inflammasome priming in mice. Theranostics 2020;10:2714-26. [PMID: 32194830 DOI: 10.7150/thno.40128] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
2 de Miguel MP, Prieto I, Moratilla A, Arias J, Aller MA. Mesenchymal Stem Cells for Liver Regeneration in Liver Failure: From Experimental Models to Clinical Trials. Stem Cells Int 2019;2019:3945672. [PMID: 31191671 DOI: 10.1155/2019/3945672] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
3 Wang H, Li X, Dong G, Yan F, Zhang J, Shi H, Ning Z, Gao M, Cheng D, Ma Q, Wang C, Zhao M, Dai J, Li C, Li Z, Zhang H, Xiong H. Toll-like Receptor 4 Inhibitor TAK-242 Improves Fulminant Hepatitis by Regulating Accumulation of Myeloid-Derived Suppressor Cell. Inflammation 2021;44:671-81. [PMID: 33083887 DOI: 10.1007/s10753-020-01366-y] [Reference Citation Analysis]
4 Weng J, Han X, Zeng F, Zhang Y, Feng L, Cai L, Liang K, Liu S, Li S, Fu G, Zeng M, Gao Y. Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs. Theranostics 2021;11:7620-39. [PMID: 34335954 DOI: 10.7150/thno.58515] [Reference Citation Analysis]
5 Sakalem ME, De Sibio MT, da Costa FADS, de Oliveira M. Historical evolution of spheroids and organoids, and possibilities of use in life sciences and medicine. Biotechnol J 2021;16:e2000463. [PMID: 33491924 DOI: 10.1002/biot.202000463] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 He YT, Qi YN, Zhang BQ, Li JB, Bao J. Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature. World J Gastroenterol 2019; 25(27): 3634-3648 [PMID: 31367162 DOI: 10.3748/wjg.v25.i27.3634] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
7 Hefler J, Marfil-Garza BA, Pawlick RL, Freed DH, Karvellas CJ, Bigam DL, Shapiro AMJ. Preclinical models of acute liver failure: a comprehensive review. PeerJ 2021;9:e12579. [PMID: 34966588 DOI: 10.7717/peerj.12579] [Reference Citation Analysis]
8 Zhu X, Zhang B, He Y, Bao J. Liver Organoids: Formation Strategies and Biomedical Applications. Tissue Eng Regen Med 2021;18:573-85. [PMID: 34132985 DOI: 10.1007/s13770-021-00357-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pluta KD, Ciezkowska M, Wisniewska M, Wencel A, Pijanowska DG. Cell-based clinical and experimental methods for assisting the function of impaired livers – Present and future of liver support systems. Biocybernetics and Biomedical Engineering 2021;41:1322-46. [DOI: 10.1016/j.bbe.2021.06.005] [Reference Citation Analysis]
10 Chamuleau RAFM, Hoekstra R. End-stage liver failure: filling the treatment gap at the intensive care unit. J Artif Organs 2020;23:113-23. [PMID: 31535298 DOI: 10.1007/s10047-019-01133-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Yan Q, Zhao XM, Deng LJ, Fang YX, Lin JJ, Li AM. Human hepatocellular adenoma as a promising cell source for bioartificial liver systems. Exp Ther Med 2019;18:1357-65. [PMID: 31316625 DOI: 10.3892/etm.2019.7673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Mendonça da Silva J, Stamatis C, Chalmers SA, Erro E, Selden C, Farid SS. Decisional tool for cost of goods analysis of bioartificial liver devices for routine clinical use. Cytotherapy 2021;23:683-93. [PMID: 34116945 DOI: 10.1016/j.jcyt.2021.04.006] [Reference Citation Analysis]
13 Wang J, Ren H, Liu Y, Sun L, Zhang Z, Zhao Y, Shi X. Bioinspired Artificial Liver System with hiPSC-Derived Hepatocytes for Acute Liver Failure Treatment. Adv Healthc Mater 2021;:e2101580. [PMID: 34599859 DOI: 10.1002/adhm.202101580] [Reference Citation Analysis]
14 Wu G, Wu D, Lo J, Wang Y, Wu J, Lu S, Xu H, Zhao X, He Y, Li J, Demirci U, Wang S. A bioartificial liver support system integrated with a DLM/GelMA-based bioengineered whole liver for prevention of hepatic encephalopathy via enhanced ammonia reduction. Biomater Sci 2020;8:2814-24. [PMID: 32307491 DOI: 10.1039/c9bm01879d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Mendonça da Silva J, Erro E, Awan M, Chalmers SA, Fuller B, Selden C. Small-Scale Fluidized Bed Bioreactor for Long-Term Dynamic Culture of 3D Cell Constructs and in vitro Testing. Front Bioeng Biotechnol 2020;8:895. [PMID: 32974291 DOI: 10.3389/fbioe.2020.00895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Li Y, Chen HS, Shaheen M, Joo DJ, Amiot BP, Rinaldo P, Nyberg SL. Cold storage of porcine hepatocyte spheroids for spheroid bioartificial liver. Xenotransplantation 2019;26:e12512. [PMID: 30968460 DOI: 10.1111/xen.12512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]